Intestinal Cell News Volume 7.40 | Oct 22 2021

    0
    59






    2021-10-22 | ICN 7.40


    Intestinal Cell News by STEMCELL Technologies
    Vol. 7.40 – 22 October, 2021
    TOP STORY

    Regulation of Intestinal Immunity and Tissue Repair by Enteric Glia

    Scientists uncovered important roles of enteric glial cells in intestinal homeostasis, immunity and tissue repair. They demonstrated that infection of mice with Heligmosomoides polygyrus led to enteric gliosis and the upregulation of an interferon gamma gene signature.
    [Nature]

    Abstract

    Free Wallchart: Dynamic Modeling in Organoids
    PUBLICATIONSRanked by the impact factor of the journal

    Mitochondrial Complex II in Intestinal Epithelial Cells Regulates T Cell-Mediated Immunopathology

    Intestinal epithelial cell (IEC) damage by T cells contributes to graft-versus-host disease, inflammatory bowel disease and immune checkpoint blockade-mediated colitis. The relevance of IEC-intrinsic succinate dehydrogenase A in mediating disease severity was confirmed by complementary chemical and genetic experimental approaches and validated in human clinical samples.
    [Nature Immunology]

    Full Article

    XBP1 Regulates the Protumoral Function of Tumor-Associated Macrophages in Human Colorectal Cancer

    Differentially expressed genes were found to be enriched in unfolded protein response/endoplasmic reticulum stress response processes, and XBP1 splicing/activation was specifically observed in tumor-associated macrophages.
    [Signal Transduction and Targeted Therapy]

    Full Article

    Complete Loss of miR-200 Family Induces EMT Associated Cellular Senescence in Gastric Cancer

    Genetic deletion of all miR-200s in the human gastric cancer cell lines induced potent morphological alterations, G1/S cell cycle arrest, increased senescence-associated β-galactosidase activity, and aberrant metabolism, collectively resembling the senescent phenotype.
    [Oncogene]

    Full Article

    OLFM4-RET Fusion Is an Oncogenic Driver in Small Intestine Adenocarcinoma

    Researchers investigated the biological effects of OLFM4-RET fusion and whether it could initiate tumorigenesis in small intestine.
    [Oncogene]

    Abstract

    BRD9 Inhibition Promotes PUMA-Dependent Apoptosis and Augments the Effect of Imatinib in Gastrointestinal Stromal Tumors

    Scientists evaluated the functional role of BRD9 in gastrointestinal stromal tumors (GIST) progression. Their findings demonstrated that the expression of BRD9 was upregulated in GIST tissues.
    [Cell Death & Disease]

    Full Article

    Everolimus and Plicamycin Specifically Target Chemoresistant Colorectal Cancer Cells of the CMS4 Subtype

    Researchers reported the finding that two clinically employed agents, everolimus and plicamycin, efficiently targeted the prototypic CMS4 cell line MDST8.
    [Cell Death & Disease]

    Full Article

    Novel Evidence for m6A Methylation Regulators as Prognostic Biomarkers and FTO as a Potential Therapeutic Target in Gastric Cancer

    Investigators investigated the expression of the N6-methyladenosine (m6A) regulator genes and their prognostic potential in a large clinical cohort of 173 gastric cancer patients using qRT-PCR assays.
    [British Journal of Cancer]

    Full Article

    Effects and Prognostic Values of miR-30c-5p Target Genes in Gastric Cancer via a Comprehensive Analysis Using Bioinformatics

    Researchers showed that miR-30c-5p expression was significantly down-regulated in gastric cancer tissues by comprehensive analysis using multiple databases.
    [Scientific Reports]

    Full Article


    Watch this innovation showcase from ISSCR 2021 on intestinal organoids as models for drug development.
    REVIEWS

    Biobanking of Human Gut Organoids for Translational Research

    Focusing on human intestinal organoids, the authors highlight some of the key aspects that need to be considered and provide an outlook for future development in this exciting field.
    [Environmental and Molecular Mutagenesis]

    Full Article

    INDUSTRY AND POLICY NEWS

    Bristol Myers Squibb Receives European Commission Approval for Opdivo (Nivolumab) + Chemotherapy for Patients with HER2 Negative, Advanced or Metastatic Gastric, Gastroesophageal Junction or Esophageal Adenocarcinoma

    Bristol Myers Squibb announced that the European Commission has approved Opdivo in combination with fluoropyrimidine- and platinum-based combination chemotherapy for the first-line treatment of adult patients with HER2-negative advanced or metastatic gastric, gastroesophageal junction, or esophageal adenocarcinoma whose tumors express PD-L1 with a combined positive score greater than equal to five.
    [Bristol Myers Squibb]

    Press Release

    FEATURED EVENT

    2nd AACR-KCA Conference on Precision Medicine in Solid Tumors

    November 10 – 11, 2021
    Seoul, Korea & Online

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Researcher – Cancer Microbiome Research

    University of Luxembourg – Luxembourg, Luxembourg

    Postdoctoral Fellow – Inflammatory Bowel Diseases

    Brigham and Women’s Hospital and Harvard Medical School – Boston, Massachusetts, United States

    Assistant Professor – Cancer Research

    University of Manitoba – Winnipeg, Manitoba, Canada

    Postdoctoral Associate – Intestinal Organoids

    Baylor College of Medicine – Houston, Texas, United States

    Postdoctoral Fellow – Breast and Colorectal Cancer

    Dalhousie University – Halifax, Nova Scotia, Canada

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Intestinal Cell News Twitter